Trial Profile
A phase I study of RG7689 in patients with Infectious disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Oct 2015
Price :
$35
*
At a glance
- Drugs RG 7689 (Primary)
- Indications Infections
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Roche
- 16 Oct 2015 New trial record